PAZOTAB(Palbociclib Hydrochloride)
Therapeutic class: Tyrosine Kinase Inhibitors
Indication: Advanced renal cell carcinoma. , Advanced soft tissue sarcoma who have received prior chemotherapy.
200mg & 400mg Tablets
200mg:-
A bottle of 30 tablets400 mg:-
A bottle of 30 tablets- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
